Clinical Trials
4 trialsNCT05907057 2026-05-08
An Open-label Phase 3b Study of Ivosidenib in Combination With Azacitidine in Adult Patients Newly Diagnosed With IDH1m Acute Myeloid Leukemia (AML) Ineligible for Intensive Induction Chemotherapy.
Servier
Phase 3 Recruiting
NCT05230758 2026-05-01
Met Med Can
The Hospital for Sick Children
Phase 3 Recruiting
NCT03016819 2026-02-25
APROMISS
Advenchen Laboratories, LLC
Phase 3 Recruiting
NCT04601116 2021-01-14
The MASTER Study (MAmmary Cancer STatin ER Positive Study)
Aarhus University Hospital
Phase 3 Recruiting